These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16213146)

  • 1. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase.
    Anagnostou E; Kosmopoulou MN; Chrysina ED; Leonidas DD; Hadjiloi T; Tiraidis C; Zographos SE; Györgydeák Z; Somsák L; Docsa T; Gergely P; Kolisis FN; Oikonomakos NG
    Bioorg Med Chem; 2006 Jan; 14(1):181-9. PubMed ID: 16213146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic studies on N-azidoacetyl-beta-D-glucopyranosylamine, an inhibitor of glycogen phosphorylase: comparison with N-acetyl-beta-D-glucopyranosylamine.
    Petsalakis EI; Chrysina ED; Tiraidis C; Hadjiloi T; Leonidas DD; Oikonomakos NG; Aich U; Varghese B; Loganathan D
    Bioorg Med Chem; 2006 Aug; 14(15):5316-24. PubMed ID: 16616506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
    Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
    Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
    Watson KA; Chrysina ED; Tsitsanou KE; Zographos SE; Archontis G; Fleet GW; Oikonomakos NG
    Proteins; 2005 Dec; 61(4):966-83. PubMed ID: 16222658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
    Oikonomakos NG; Kontou M; Zographos SE; Watson KA; Johnson LN; Bichard CJ; Fleet GW; Acharya KR
    Protein Sci; 1995 Dec; 4(12):2469-77. PubMed ID: 8580837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
    Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
    Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
    Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of beta-D-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies.
    Chrysina ED; Kosmopoulou MN; Kardakaris R; Bischler N; Leonidas DD; Kannan T; Loganathan D; Oikonomakos NG
    Bioorg Med Chem; 2005 Feb; 13(3):765-72. PubMed ID: 15653344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
    Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
    Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
    Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN
    Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Consistency of Structure-Based Design and X-Ray Crystallography: Design, Synthesis, Kinetic Evaluation and Crystallographic Binding Mode Determination of Biphenyl-
    Fischer T; Koulas SM; Tsagkarakou AS; Kyriakis E; Stravodimos GA; Skamnaki VT; Liggri PGV; Zographos SE; Riedl R; Leonidas DD
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
    Andersen B; Westergaard N
    Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
    Leonidas DD; Oikonomakos NG; Papageorgiou AC; Acharya KR; Barford D; Johnson LN
    Protein Sci; 1992 Sep; 1(9):1112-22. PubMed ID: 1304390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
    Oikonomakos NG; Tiraidis C; Leonidas DD; Zographos SE; Kristiansen M; Jessen CU; Nørskov-Lauritsen L; Agius L
    J Med Chem; 2006 Sep; 49(19):5687-701. PubMed ID: 16970395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.
    Oikonomakos NG; Kosmopoulou M; Zographos SE; Leonidas DD; Chrysina ED; Somsák L; Nagy V; Praly JP; Docsa T; Tóth B; Gergely P
    Eur J Biochem; 2002 Mar; 269(6):1684-96. PubMed ID: 11895439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of heterocyclic N-(β-D-glucopyranosyl)carboxamides for inhibition of glycogen phosphorylase.
    Kónya B; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2012 Apr; 351():56-63. PubMed ID: 22365837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.
    Anderka O; Loenze P; Klabunde T; Dreyer MK; Defossa E; Wendt KU; Schmoll D
    Biochemistry; 2008 Apr; 47(16):4683-91. PubMed ID: 18373353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.